SARAH SMITH: Open Payments
NPI 1750643706 · WALTHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,463 in 112 payments from 20 companies in 2025. Trend: 2023 $1,191 · 2024 $1,211 · 2025 $2,463
Food & beverage: $2,463
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $690 |
| Lundbeck LLC | 10 | $374 |
| Novo Nordisk Inc | 10 | $160 |
| Neurelis, Inc. | 4 | $153 |
| MERZ NORTH AMERICA, INC. | 1 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $128 |
| PFIZER INC. | 5 | $106 |
| LivaNova USA, Inc. | 1 | $104 |
| ARGENX US, INC. | 3 | $94 |
| Aucta Pharmaceuticals, Inc. | 3 | $76 |
Products named: QULIPTA, VYEPTI, UBRELVY, VALTOCO, Xeomin, WAINUA, REXULTI, NURTEC ODT.
Industry payments across MA — which companies pay providers there.
